Partial Cystectomy for Muscle-Invasive Bladder Cancer
Cancers · 03.08.2025 · 17 (15) · 2562
DOI: 10.3390/cancers17152562 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 03.08.2025. Verfasst von Peter S Palencia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Yale School of Medicine, New Haven, CT 06520, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Partial cystectomy is a surgical bladder-sparing option for selected patients with muscle-invasive bladder cancer (MIBC), urachal adenocarcinoma and diverticular bladder tumors. Partial cystectomy hold several advantages. It allows for definite pathology and accurate staging while avoiding side effects from radiation therapy and preserves the option for salvage radical therapy (radical cystectomy or radical radiotherapy). Patients should have a CT urogram, prostatic urethral biopsy and mapping biopsies or blue light cystoscopy to rule out multifocal disease or CIS. Small solitary MIBC patients without carcinoma in situ in an area of the bladder where resection can be performed with negative margin would be the ideal candidates for partial cystectomy. Neoadjuvant systemic therapy is recommended for patients undergoing partial cystectomy. Partial cystectomy can be performed either by open or robotic approaches. When compared to radical cystectomy, partial cystectomy affords a lower complication rate and length of stay and better quality of life. Recurrence-free survival, cancer-specific survival and overall survival at 5 years is 39–67%, 62–84% and 45–70%, respectively. Following partial cystectomy, patients should have three monthly cystoscopy and urinary cytology for the first 24 months followed by 6-monthly cystoscopy for year 3 and 4 and then yearly for life. Cross-sectional imaging should be performed every 3–6 months for the first 2–3 years and then annually for 5 years.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Yale School of Medicine, New Haven, CT 06520, USA.
- Department of Urology, University College London Hospitals, London W1G 8PH, UK.
- Division of Surgery & Interventional Science, University College London, London W1W 7TY, UK.
- Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
ORCID-Profile: Peter S Palencia, Nethusan Sivanesan, Fady Ghali, Ashwin Sridhar, Byron H Lee, Wei-Shen Tan
Zitieren
APA
Palencia, P. S., Sivanesan, N., Rahman, S., Ghali, F., Hesse, D., Colberg, J., Sridhar, A., Kelly, J. D., Lee, B. H., Kamat, A. M., & Tan, W. S. (2025). Partial Cystectomy for Muscle-Invasive Bladder Cancer. Cancers, 17(15), 2562. https://doi.org/10.3390/cancers17152562
Vancouver
Palencia PS, Sivanesan N, Rahman S, Ghali F, Hesse D, Colberg J, et al. Partial Cystectomy for Muscle-Invasive Bladder Cancer. Cancers. 2025;17(15):2562. doi:10.3390/cancers17152562
BibTeX
@article{Palencia2025,
author = {Palencia, Peter S and Sivanesan, Nethusan and Rahman, Syed and Ghali, Fady and Hesse, David and Colberg, John and Sridhar, Ashwin and Kelly, John D and Lee, Byron H and Kamat, Ashish M and Tan, Wei-Shen},
title = {Partial Cystectomy for Muscle-Invasive Bladder Cancer},
journal = {Cancers},
year = {2025},
volume = {17},
number = {15},
pages = {2562},
doi = {10.3390/cancers17152562}
}
EUVIMED